Dr. Shune is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Shawnee Mission Pkwy
Ste 210
Westwood, KS 66205Phone+1 913-588-6030Fax+1 913-588-4085
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2010 - 2013- University of MinnesotaResidency, Internal Medicine, 2007 - 2010
Istanbul University FomClass of 2004
Certifications & Licensure
KS State Medical License 2014 - 2025
MO State Medical License 2021 - 2025
Clinical Trials
- Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients Start of enrollment: 2021 Nov 02
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 50 citationsSocioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access.Nausheen Ahmed, Moazzam Shahzad, Ernie Shippey, Rajat Bansal, Muhammad Umair Mushtaq
Transplantation and Cellular Therapy. 2022-07-01 - 33 citationsA Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.Michael J Dickinson, Pere Barba, Ulrich Jäger, Nirav N Shah, Didier Blaise
Cancer Discovery. 2023-09-06 - 64 citationsRandomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation fo...Leo Luznik, Marcelo C. Pasquini, Brent R. Logan, Robert J. Soiffer, Juan Wu
Journal of Clinical Oncology. 2021-12-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
